𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Single center prospective study of tacrolimus efficacy and safety in the treatment of various manifestations in systemic lupus erythematosus

✍ Scribed by Katsuya Suzuki; Hideto Kameda; Koichi Amano; Hayato Nagasawa; Hirofumi Takei; Eiko Nishi; Ayumi Okuyama; Kensei Tsuzaka; Tsutomu Takeuchi

Publisher
Springer
Year
2010
Tongue
English
Weight
389 KB
Volume
31
Category
Article
ISSN
0172-8172

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Safety and efficacy of tumor necrosis fa
Safety and efficacy of tumor necrosis factor Ξ± blockade in systemic lupus erythematosus: An open-label study
✍ Martin Aringer; Winfried B. Graninger; GΓΌnter Steiner; Josef S. Smolen πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 116 KB πŸ‘ 1 views

## Abstract ## Objective To investigate the safety of therapeutic tumor necrosis factor Ξ± (TNFΞ±) blockade in patients with systemic lupus erythematosus (SLE), in whom this proinflammatory cytokine is significantly increased and may be involved in the disease pathogenesis. ## Methods In an open‐l

Efficacy and safety of rituximab in mode
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
✍ Joan T. Merrill; C. Michael Neuwelt; Daniel J. Wallace; Joseph C. Shanahan; Kevi πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 499 KB πŸ‘ 2 views

## Abstract ## Objective B cells are likely to contribute to the pathogenesis of systemic lupus erythematosus (SLE), and rituximab induces depletion of B cells. The Exploratory Phase II/III SLE Evaluation of Rituximab (EXPLORER) trial tested the efficacy and safety of rituximab versus placebo in p